Back to mobile site

Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: Nantahala Capital Management, LLC

May 15, 2026 4:43 PM EDT





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



 
Nantahala Capital Management, LLC
 
Signature:/s/ Taki Vasilakis
Name/Title:Taki Vasilakis / Chief Compliance Officer
Date:05/15/2026
 
Wilmot B. Harkey
 
Signature:/s/ Wilmot B. Harkey
Name/Title:Wilmot B. Harkey
Date:05/15/2026
 
Daniel Mack
 
Signature:/s/ Daniel Mack
Name/Title:Daniel Mack
Date:05/15/2026


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G